Exact FDA event identifier

Event 86929

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: November 25, 2020
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: US Compounding Inc

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05

D-0175-2021

Recall number: D-0175-2021
Initiated: November 25, 2020
Classification: Class III
Status: Terminated
Recalling firm: US Compounding Inc
Quantity: 1640 syringes

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

Missing label

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labelling: Missing label.

Code information

Lot: 20202109@3 BUD: 3/20/2021

Distribution pattern

Nationwide